Immune Status After Being on Call for 24 Hrs
Launched by UNIVERSITY OF CHICAGO · Oct 9, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how staying awake for 24 hours affects the immune system, particularly in surgery residents who often work long shifts without sleep. Researchers want to understand if being sleep-deprived leads to an increase in inflammation and a decrease in the body’s ability to fight off infections. The results could help shed light on how sleep deprivation impacts health, especially for those in demanding medical careers.
To participate in this study, individuals need to be healthy surgery residents aged 18 or older, regardless of gender or background. They must be able to give consent to join the trial. Participants will undergo assessments to examine their immune cells and how they function after a long shift, alongside some health measurements. This study aims to gather important information that could improve the well-being of medical professionals who frequently face sleep deprivation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy subjects
- • Surgery residents in a 24-hour shift rotation
- • Gender of subjects: Males and females
- • Age of subjects: 18 years old and older
- • Racial and Ethnic Origin: Any race or ethnicity
- Exclusion Criteria:
- • Unwilling/unable to sign informed consent
- • Vulnerable Subjects/Subject Capacity to provide consent
About University Of Chicago
The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Angelica Perez-Gutierrez, MD
Principal Investigator
University of Chicago
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported